Pathos AI uses AI to accelerate drug development by optimizing patient selection, biomarker development, and clinical trial design, focusing on precision medicine.

X37

Web

drug development

X37 is an AI-driven drug development company that focuses on difficult-to-target proteins across a broad chemical space, aiming to create safe and effective therapies.

Tevogen.AI

Web

drug development

Tevogen.AI aims to enhance patient access by utilizing artificial intelligence-powered tools, focusing on developing foundational models for its PredicTcell platform to accelerate drug development.